KIF18B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.661800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.236000E-01
Normal-vs-Stage2
3.123600E-01
Normal-vs-Stage3
5.739600E-01
Normal-vs-Stage4
8.640600E-01
Stage1-vs-Stage2
1.925390E-01
Stage1-vs-Stage3
4.822800E-01
Stage1-vs-Stage4
9.092600E-01
Stage2-vs-Stage3
7.777800E-01
Stage2-vs-Stage4
3.322400E-01
Stage3-vs-Stage4
5.985600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.491400E-01
Normal-vs-AfricanAmerican
6.456600E-01
Normal-vs-Asian
3.845800E-01
Caucasian-vs-AfricanAmerican
7.611000E-01
Caucasian-vs-Asian
5.905800E-01
AfricanAmerican-vs-Asian
9.522600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.732800E-01
Normal-vs-Female
3.638200E-01
Male-vs-Female
4.604000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.637600E-01
Normal-vs-Age(41-60Yrs)
3.503800E-01
Normal-vs-Age(61-80Yrs)
3.834200E-01
Normal-vs-Age(81-100Yrs)
2.877000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.586000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.762200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.023200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.930000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.380400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.107800E-01
Normal-vs-Daily Drinker
4.717200E-01
Normal-vs-Weekly Drinker
3.109400E-01
Normal-vs-Occasional Drinker
3.542800E-01
Normal-vs-Social Drinker
2.898600E-01
Non Drinker-vs-Daily Drinker
8.146200E-01
Non Drinker-vs-Weekly Drinker
2.569400E-01
Non Drinker-vs-Occasional Drinker
6.362800E-01
Non Drinker-vs-Social Drinker
5.333000E-01
Daily Drinker-vs-Weekly Drinker
2.154600E-01
Daily Drinker-vs-Occasional Drinker
5.199600E-01
Daily Drinker-vs-Social Drinker
4.291400E-01
Weekly Drinker-vs-Occasional Drinker
4.007800E-01
Weekly Drinker-vs-Social Drinker
4.774800E-01
Occasional Drinker-vs-Social Drinker
8.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.911400E-01
Normal-vs-Grade 2
6.655200E-01
Normal-vs-Grade 3
6.828800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.319100E-03
Grade 1-vs-Grade 3
9.394200E-04
Grade 1-vs-Grade 4
5.911400E-01
Grade 2-vs-Grade 3
4.952400E-01
Grade 2-vs-Grade 4
6.655200E-01
Grade 3-vs-Grade 4
6.828800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.886000E-01
Normal-vs-NonDiabetic
3.137000E-01
Diabetic-vs-NonDiabetic
8.463900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.132980E-01
Normal-vs-NoPancreatitis
4.154800E-01
Pancreatitis-vs-NoPancreatitis
1.010450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.680600E-01
Normal-vs-N1
3.410400E-01
N0-vs-N1
5.197400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.026000E-02
Normal-vs-TP53-NonMutant
4.933200E-01
TP53-Mutant-vs-TP53-NonMutant
3.66239999993745E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
